Article

Risk management recommendations

Informed consent

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Subscribe Now!
Related Videos
Related Content
Cosmetic procedures associated with serious ophthalmologic complications
August 8th 2025

Cosmetic procedures associated with serious ophthalmologic complications

3 Things You Should Know About the GA Pipeline
August 8th 2025

3 Things You Should Know About Interventional Glaucoma Comanagement

Q&A: Michael Lai, MD, PhD, on the impact of underfunding the Good Days program
August 8th 2025

Q&A: Michael Lai, MD, PhD, on the impact of underfunding the Good Days program

Patient-Centered Treatment Strategies in the Management of nAMD and DME
August 8th 2025

Patient-Centered Treatment Strategies in the Management of nAMD and DME

Clearside Biomedical's Xipere (triamcinolone acetonide injectable suspension) approved by Health Canada
August 8th 2025

Clearside Biomedical's Xipere (triamcinolone acetonide injectable suspension) approved by Health Canada

Q&A: PER-001 showed improved structure and visual function in patients with diabetic retinopathy
August 8th 2025

Q&A: PER-001 showed improved structure and visual function in patients with diabetic retinopathy

© 2025 MJH Life Sciences

All rights reserved.